Breakout Sessions

The Case for Vertical Integration: Do Replicable Models Exist?

Friday, April 13, 2018 - 10:30 AM - 11:30 AM

Vertical integration between payors and providers is increasing and evolving, taking shape in models that span the range from full to partial allocation of risk. Large, integrated health systems have existed for decades in a few markets and some have demonstrated the ability to provide high quality services while controlling costs. More recently, accountable care organizations have formed to internalize financial risk within a provider network while seeking to maintain quality. Novel partnerships between insurers and health systems are also emerging, offering alternatives to full integration that nonetheless attempt to align incentives and reallocate risk. Can vertical integration keep costs down and quality up? Which models work, and how can they be scaled? After a brief overview of trends in value-based care and integration, panelists will detail their organization’s approach to integration, results, and potential replicability. The implications of vertical payor-provider integration for broader health system reform will be examined.

 Tom Bulleit  Ropes & Gray  (Moderator)

Tom Bulleit, JD

Partner

Ropes & Gray

Tom Bulleit represents a wide range of clients in all sectors of the healthcare industry, from academic medical centers and companies engaged in biomedical research and development, to large and small manufacturers of medical devices and pharmaceuticals, to HMOs and other healthcare payors, to hospitals, hospices, physicians, physician practice management companies, physical therapists, and other hands-on providers of healthcare, to niche companies offering unconventional services such as e-health connectivity. Tom's practice focuses on legal and regulatory compliance, coverage, and reimbursement, especially under Medicare and other federal healthcare programs but also under state licensing and regulatory regimes, as a counselor, a business lawyer, and an advocate. A primary focus of Tom's practice has been compliance with health regulatory requirements, especially the healthcare fraud and abuse laws. He strives to provide counseling that allows clients to meet legal requirements while still engaging in competitive business arrangements. His counseling practice includes internal client audits and the development of compliance plans, policies, and standard operating procedures. Because the fraud and abuse rules often dictate or heavily influence the permissibility of financial relationships in the healthcare industry, Tom’s regulatory experience has led his healthcare and investor clients to engage him extensively for strategic analysis, development and negotiation of business deals, including academic affiliation agreements between medical schools and their teaching hospitals, and between academic medical centers and community healthcare providers, contracts for healthcare professional services and employment, medical product purchase and sale, discounts and rebates,asset purchases, and regulatory “due diligence” in both the public and private company arenas. Tom also advises in other key areas of health regulation, including coverage and reimbursement, provider payment sunshine laws, digital health and information privacy, and clinical research. He also represents clients who are under investigation by the U.S. Department of Health and Human Services Office of Inspector General, the U.S. Department of Justice, and state Attorneys General, including the negotiation and implementation of Corporate Integrity Agreements and Deferred Prosecution Agreements.

 Tom Bulleit  Ropes & Gray  (Moderator)

Sanjay Doddamani, MD

CMO, Keystone ACO, Geisinger

Dr. Sanjay Doddamani is the Chief Medical Officer of the Geisinger led Keystone ACO, and a Senior Director, in Population Health, at Geisinger Health System. In this capacity, he works with the executive leadership to accelerate improvement of performance metrics across the system, working closely with the service line medical directors, platform leaders, and operational leadership, to improve integration of population health initiatives. He is also the System-wide Chief of the Advanced Cardiac Disease – Heart Failure program for Geisinger Health System. His background as a heart failure cardiologist has kept him interested in chronic disease management aspects of heart failure. Additionally, he oversees the LVAD program for mechanical circulatory (heart pump) support. Dr. Doddamani is board certified in Internal Medicine and Cardiology, as well as in heart failure and cardiac transplant. He has served on numerous panels and committees, as well as delivered lectures, both nationally and abroad, related to heart health and disease.

 Tom Bulleit  Ropes & Gray  (Moderator)

Joe Scheidler, MBA

Vice President, National Accounts

Kaiser Permanente

Joe Scheidler is Vice President, National Accounts for Kaiser Permanente. In his role, Scheidler leverages over 25 years of expertise in healthcare, health and management consulting and financial services to lead account management and sales for the organization’s national employer group business line with primary focus on contributing to the organization’s sustainable membership growth. Among previous roles at Kaiser Permanente, Scheidler most recently served as the Vice President of National and Multi-State Sales where he successfully led multi-disciplinary sales teams and served as a Senior Executive Account Manager where he drove accelerated growth with large, complex customers including Walmart, The Home Depot and United Auto Workers VEBA Trust, among others. Prior to joining Kaiser Permanente in 2006, Scheidler held senior brand and corporate strategy positions with the Blue Cross Blue Shield Association. Earlier in his career, Scheidler served in a number of roles in compensation, management and strategy consulting at the Mitchell Madison Consulting Group and Watson Wyatt Worldwide. Scheidler holds a Master’s degree in business administration from Yale University, completed an executive program at Harvard Business School and received his Bachelor of Science degree in Business and Finance from Northern Illinois University. He is an active participant in several influential industry organizations including the National Business Coalition on Health.

Al Kurose

Al Kurose, MD, MBA

President & CEO

Coastal Medical

Al Kurose, MD, is President and CEO of Coastal Medical, a primary care driven Accountable Care Organization (ACO). Coastal Medical provides care to 120,000 patients in more than 20 medical offices across Rhode Island.

Dr. Kurose has led Coastal Medical since 2008, and has been a driving force behind Coastal’s transition to accountable care. He is a member of the Policy Committee for the National Association of ACO’s (NAACOS) and the Healthcare Executive Advisory Council for UnitedHealth Group.

Dr. Kurose is a graduate of the Washington University School of Medicine in St. Louis, MO; the Brown University Internal Medicine Residency Training Program and the Yale MBA for Executives Program. He is one of the founders of Coastal Medical, and practiced primary care internal medicine in a community-based office for 20 years. He is a Clinical Assistant Professor of Health Services, Policy & Practice at Brown University.

Al Kurose

Cassandra Toscano, MBA

Executive Director of Joint Venture Clinical Transformation

Aetna

Cassandra currently serves as Aetna’s Executive Director of Joint Venture Clinical Transformation. In this role, she is responsible for the clinical and financial performance of three Joint Ventures, accounting for approximately 300k members and $1 billion in medical spend. At Aetna, she has also led ACO clinical transformation from DC to Maine.

Cassandra has always worked in roles which blend financial, clinical, and innovation acumen. Before joining Aetna, Cassandra was Director of ACOs for EmblemHealth, led value-based contract implementation and clinical design at PwC, and worked in hospital finance and administration for Partners Healthcare System.

She is dedicated to transforming healthcare delivery into a financially sustainable, clinically reliable, and customer-friendly environment. Cassandra received her bachelors of arts in Biology from Boston University and her masters of business administration from Yale University.


Frontiers of Healthcare Technology: The Role of Telemedicine and Patient-Centered Innovation 

Friday, April 13, 2018 - 10:30 AM - 11:30 AM

As the healthcare industry continues to innovate to expand and improve care, technological solutions have become increasingly important. This session will focus on advancements such as telemedicine, remote patient monitoring, and other critical technologies emerging that are aimed at improving patient health experience. Panelists will discuss the advances these technologies have made and barriers for future adoption. The Healthcare Technology panel will bring together speakers from organizations that have designed and implemented telemedicine and RPM programs, or have utilized technology in personalized medicine to drive innovation, enhance healthcare quality or improve access.

 Jared Augenstein    Manatt Health Solutions  (Moderator)

Jared Augenstein, MPH, MA

Senior Manager

Manatt Health

Jared Augenstein is a senior manager with Manatt Health, an interdisciplinary policy and business advisory practice of Manatt. He provides strategic consulting services, project management, policy analysis, and startup business planning to healthcare providers, startups, payers, pharmaceutical manufacturers and other healthcare organizations. Jared’s primary areas of focus are advising public- and private-sector clients on delivery system transformation, population health, digital health, international and global health, federal and state health policy trends and provider markets. Jared has extensive experience assisting large health systems, academic medical centers, and children’s hospitals with strategic planning and implementation efforts related to delivery system transformation, health technology and digital health, population health infrastructure development, and organizational restructuring. He also advises healthcare startups on business planning strategies.

  Liz Asai    3Derm

Elizabeth Asai

CEO & Co-Founder

3Derm Systems

Liz Asai has served as CEO of 3Derm Systems, Inc. since 2013. Prior to co-founding 3Derm in 2012, she conducted research on telemedicine technologies and served as principal investigator of a teledermatology clinical study at the Yale School of Medicine. With Liz as CEO, 3Derm has raised over $4M in funding, built teledermatology networks of primary care and dermatology clinics, and obtained reimbursement from several major health insurers. She led the team through three clinical studies over five years before entering the market in 2016. Liz is actively involved with local and national health tech policy groups drafting testimony and legislation advocating for telemedicine reimbursement. Liz holds a bachelor’s degree in Biomedical Engineering from Yale University and was featured in Forbes 30 Under 30.

  Adam Licurse   Partners Healthcare

Adam Licurse, MD, MHS

Associate Medical Director

Brigham and Women's Physicians Organization, Partners Population Health Management

Adam Licurse is an associate medical director at the Brigham and Women’s Physicians Organization, and an associate medical director at Partners Population Health Management. He practices primary care at the South Huntington primary care practice. At BWH, he leads a number of population health and care redesign efforts, including the Brigham’s patient reported outcome measure (PROMs) program, and its ambulatory Telehealth efforts: E-Visits, Virtual Visits, and E-Consults. In his Partners Population Health Management role, he directs the strategy and implementation of the group's multiple patient engagement and telehealth programs, including efforts in shared decision making, in-office and virtual patient education, online patient communities, remote monitoring, patient texting, and virtual patient self-management. He has published multiple articles about evidence-based clinical decision-making and financial ties to industry, teaches in BWH’s Clinical Process Improvement Program and the ambulatory curriculum of the BWH medical residency program, and has been an invited panelist and speaker at numerous national conferences on population health, telehealth, and patient engagement. Adam completed residency training in Internal Medicine at BWH, and earned his MD and MHS at Yale School of Medicine where he graduated cum laude. He graduated from Yale College.

Al Kurose

Michel Denarié, MBA

Senior Principal, Data Scientist

IQVIA

Michel Denarié, after serving the last two years as global COE for Patient Insights, recently joined the Evidence-Driven Design team, a group that designs clinical trials, reviews protocols, and conduct licensing candidate due diligence for biopharma sponsors. He will be leveraging the various secondary data assets available across the globe to validate protocol and country selection, and accelerate patient recruitment . His area of expertise covers all the legacy IMS data assets that can be leveraged world-wide to support clinical development, including trial design, protocol validation, and site selection. Denarié’s experience in the pharmaceutical industry spans three decades and encompasses roles in sales, marketing, and offering development, with particular emphasis on longitudinal patient data and commercial effectiveness applications. Prior to IMS, Denarié was senior director, Product Management, Sales Force Effectiveness, at Verispan LLC.  In this role, he was responsible for developing groundbreaking patient-centric, prescriber-level data products and implementing live field solutions. During this time, he also developed and launched the industry’s first patient-centric physician targeting tool.  Earlier in his career, Denarié was Vice President of Marketing at McKessonHBOC Technology Solutions Division, where he developed and implemented the marketing strategy for a new, leading-edge pharma-centric analytical software suite.   A frequent author and speaker, Denarié’s work has appeared in several trade publications. He has presented research findings and methodologies regarding the advanced application of patient-level data at numerous industry conferences, including events sponsored by the Pharmaceutical Management Science Association (P.M.S.A.), the Pharmaceutical Research Group (PMRG), the International Society for Pharmacoeconomics and Outcomes Research (I.S.P.O.R), and the Association of Clinical Research Professionals (ACRP). Denarié earned an M.B.A. from the Colgate Darden Graduate School of Business Administration at the University of Virginia. He holds a B.S. in finance from American University in Washington, DC.


The Price is Right? U.S. Pharmaceutical Pricing Transparency and Sustainability

Friday, April 13, 2018 - 10:30 AM - 11:30 AM

High and increasing price tags on brand medications in the U.S. pharmaceutical market have made headlines and drawn public ire in recent years – but how high is too high? What is the standard of care to which we are comparing these advancements and their prices? This session will focus on the nuances of product pricing for biologics, biosimilars and orphan drugs compared to small-molecule pharmaceuticals, and will address how the landscape of federal policy and varied stakeholders’ incentives in the U.S. life sciences industry have impacted the prices patients and payers face. The session will bring together perspectives from academia, the private and public sectors to discuss how U.S. policy and industry innovation have led to modern prices and what the future of pharmaceutical product pricing holds.

  Aaron Hakim    Yale School of Medicine  (Moderator)

Aaron Hakim, MS, MD Candidate

Yale School of Medicine

Aaron is a third-year MD student at the Yale School of Medicine. He graduated summa cum laude and Phi Beta Kappa from Yale University with an M.S. in Molecular, Cellular and Developmental Biology and a B.S. in Economics and Molecular Biology. His Master’s thesis was published in and featured on the cover of the Journal of Biological Chemistry, and his more recent work has appeared in JAMA and JAMA Internal Medicine. His research interests include the costs, availability, and use of prescription drugs in the United States. Prior to medical school, Aaron was an Associate at a life sciences investment fund in Greenwich, CT.

  Greg Licholai    Trinity Partners

Greg Licholai, MD

Chief Medical and Information Officer

PRA Health Systems

Greg is Chief Medical and Information Officer at PRA Health Sciences, a leading pharmaceutical service, healthcare data and contract research provider. Previously, he was President and Chief Medical Officer at Castle Creek Pharmaceuticals, founder and President of Elipdera Therapeutics at Moderna, worked at McKinsey & Co., Quintiles, Inc., Proteostasis, Amicus Therapeutics, Domain Associates and Medtronic Neurological. He was co-founder of Immunome. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University, and Boston College. He trained at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He is on faculty at the Yale School of Management.

  Bob Lahman    Optum

Bob Lahman

Senior Vice President, Industry Relations

OptumRx

Bob Lahman currently serves as Senior Vice President of Industry Relations for OptumRx and has been with OptumRx since 2008. In this capacity, his primary responsibilities include rebate negotiation and contracting for commercial, Medicare, and Medicaid lines of business, specialty pharmacy contracting, and procurement for the OptumRx mail order and specialty pharmacies.

During his tenure at OptumRx, Bob’s key contributions include expanding and improving procurement initiatives with manufacturers as well as through wholesaler contracting for both brands and generics, and developing rebate process and strategies to improve overall rebate value for the organization. Bob also works across the United HealthCare organization to maximize value creation for the United Benefit organizations and OptumRx, and has worked with OptumRx Sales and Consultant Account Teams to help create and improve the OptumRx value story to the marketplace.

Before coming to OptumRx, Bob spent 28 years with Wyeth Pharmaceuticals, with nearly 20 years in sales management and over 12 years in managed markets. Bob held several key positions at Wyeth including Vice President of Health Care Systems Sales. Throughout his career, Bob received numerous professional awards, including the President’s Golden Circle Award.

Bob received his Bachelor of Arts degree in biology from California State University, Fresno.

   Eric Tichy    YNHHS

Eric Tichy, PharmD, MBA

Clinical Pharmacy Manager

Yale-New Haven Hospital

Eric Tichy obtained his Doctor of Pharmacy from the University of Connecticut, and completed his postgraduate pharmacy residency training at Yale New Haven Hospital and is completing a Masters of Business Administration from Yale University School of Management. He now works at Yale New Haven Health System where he is Associate Director, Clinical Pharmacy Services. Dr Tichy’s professional interests include leadership, immunology, plasma protein therapeutics and transplantation.

He is past chair of the American Society of Transplantation’s Transplant Pharmacy Community of Practice, past president of the Connecticut Society of Health-System Pharmacists, and contributing editor in therapeutics for the American Journal of Health-System Pharmacy. Dr Tichy has held leadership positions in state and national pharmacy and medical organizations, is a Fellow of the American College of Clinical Pharmacy and the American Society of Transplantation, has published over thirty book chapters and journal articles, presented research at national medical meetings, and has been recognized for outstanding service at Yale New Haven Hospital.

Nandini Hadker

Nandini Hadker

Principal

Trinity Partners

An Economist by training, Nandini is a Principal at Trinity Partners with two decades of experience in the consulting industry. She is motivated by translating her clients’ business objectives into bespoke research designs, analytical methods and multivariate statistics. Combining her expertise in primary and secondary research methods, with HEOR and Market Access, Nandini helps her clients identify the key clinical and economic value drivers of their asset and effectively communicate that to Payers, Physicians, Patients and Caregivers.

Prior to joining Trinity, Nandini worked at United Biosource Corporation (now Evidera), as Managing Director, developing and leading the Commercial Strategy and Reimbursement practice. She defined success by her client’s ability to drive important internal decisions, including strategic pricing, product positioning and messaging, using outcomes and evidence. Prior to that, Nandini was an Executive Director and Principal at Abt BioPharma Solutions where she led the Commercial Strategy Group.

Nandini has a Master’s degree in Economics from Boston University. Her research has been widely published at conferences and in peer reviewed pharmacoeconomic and clinical journals. She has been a speaker at PMRG, and the lead feature in Boston Herald’s 2010 special edition on “Women Leaders under 40”.


When Access Should be Limited: Combating Waste and Overutilization in US Healthcare

Friday, April 13, 2018 - 10:30 AM - 11:30 AM

With the Choosing Wisely® initiative and others like it, there is a newfound focus on preventing wasteful or unnecessary treatment in healthcare. This session will explore various ways in which delivery providers and insurers are countering overutilization and promoting high value care. How should we educate patients and providers on this topic and change prevailing views that “more is always better”? Which solutions are most successful for limiting unnecessary services? 

   Will Schpero    Yale Ph.D.  (Moderator)

William Schpero

PhD Candidate in Health Policy & Management

Yale University

William Schpero is a Ph.D. candidate studying health policy and economics at Yale University. He uses theoretical models from behavioral and public economics to evaluate the provision of health insurance and health care to low-income populations. Schpero’s current research is broadly focused on examining the efficiency of private markets for public health insurance, particularly in the context of the U.S. Medicaid program.

In past work, he has also studied the drivers of unnecessary care and evaluated the performance of accountable care organizations. His research has appeared in a number of academic journals, including Health Affairs, Health Services Research, JAMA, and the Journal of General Internal Medicine, and has been featured by Bloomberg, CNBC, Politico, The Washington Post, and other publications. Before coming to Yale, Schpero completed a research fellowship at The Dartmouth Institute for Health Policy & Clinical Practice, from which he also received a master’s degree. He received his undergraduate degree from Dartmouth College.

   Emad Rizk    Verscend Technologies

Jordan Bazinsky

Executive Vice President of Product and Strategy

Verscend

As executive vice president of product and strategy, Jordan oversees Verscend’s product portfolio, analytics, and marketing with a focus on innovation. He is committed to advancing our clients’ goals through solutions that empower their success amid an evolving landscape. To that end, he is responsible for ensuring that Verscend’s strategic vision aligns with our clients, and the broader healthcare marketplace.

Jordan joined Verscend in 2009 and has held various senior leadership roles during his tenure across operations, data science, finance, human resources, and risk management. Jordan has more than 15 years of healthcare experience. Prior to joining Verscend, Jordan held positions in strategy and new product development at The Advisory Board Company, a healthcare consulting and technology firm. Jordan earned an MBA from Harvard University and an undergraduate degree from Duke University, where he previously served as a trustee.

  Robert Fogerty    Yale School of Medicine

Robert L. Fogerty, MD, MPH, SFHM

Associate Professor, Yale School of Medicine & Director of Bed Resources

Yale New Haven Hospital

After receiving his Bachelor’s degree in Economics from Boston College, Robert L. Fogerty received his MD and MPH degrees from Northwestern University and completed training in Internal Medicine at Yale-New Haven Hospital. In 2011, he joined the Yale faculty as a founding member of the Academic Hospitalist Program, where he currently is an Associate Professor and is Co-Director for the Quality Improvement & Physician Leadership Distinction.

His academic interests include safety and quality of care in the inpatient setting, and cost-effective care. In his position as Director, Bed Resources for Yale New Haven Hospital, known institutionally as the “Bed Czar,” Dr. Fogerty holds administrative responsibility for the allocation and utilization of the 1,541 licensed beds at Yale New Haven Hospital, one of the largest hospitals in the United States and he remains clinically active on the inpatient general medicine service. Publications include the Journal of Hospital Medicine, JAMA Internal Medicine, and The New England Journal of Medicine. He is a Senior Fellow of Hospital Medicine and holds leadership positions in the Society of Hospital Medicine and the Society of General Internal Medicine.

  Shannon Brownlee    Harvard Lown Institute

Shannon Brownlee, MSc

Senior Vice President

Lown Institute & Visiting Scientist, Harvard T.H. Chan School of Public Health

Shannon Brownlee, MSc, is senior vice president of the Lown Institute. She and Lown Institute president Dr. Vikas Saini are co-founders of the Right Care Alliance, a network of activist patients, clinicians, and community leaders devoted to organizing a broad-based movement for a radically better health care system. Before joining the Lown Institute, Brownlee served as acting director of the health policy program at the New America Foundation. As a senior fellow at New America, she published the groundbreaking book, Overtreated: Why Too Much Medicine is Making Us Sicker and Poorer, which was named the best economics book of 2007 by the New York Times.

She was a senior writer at US News and World Report and Discover Magazine, and is the recipient of numerous awards, including a Congressional Commendation, and was named one of “four writers who changed the world” by the World Congress of Science Journalists. Her stories and essays have appeared in such publications as The Atlantic, New York Times Magazine, The Washington Post, Times of London, Time, New Republic, Los Angeles Times, BMJ, The Lancet, and Health Affairs. Brownlee is a nationally recognized speaker, has been featured in several documentary films, and has appeared on such broadcast outlets as the ABC World News, Good Morning America, Fox News, NPR, and the Diane Rehm Show, and is quoted regularly in the press. She is the author of several peer-reviewed articles in medical journals and has served on numerous scientific panels, working groups, and roundtables. From 2014-16 she was an editor of the “Less is More” section of JAMA Internal Medicine, and was a lecturer from 2011-14 at the Dartmouth Institute for Health Policy and Clinical Practice.

She is currently a member of the boards of the Robert Graham Center of the American Academy of Family Practice and FamiliesUSA, and is a visiting scientist at the Harvard T.H. Chan School of Public Health. Brownlee holds a master’s degree in marine science from the University of California, Santa Cruz.

Todd Staub, MD

Senior Vice President

UnitedHealth Group’s Optum business

Todd Staub, MD, FACP, serves as Senior Vice President for Physician Relations at OptumCare, a division of UnitedHealth Group’s Optum business. Todd is involved in the growth and development of Optumcare as a nationwide ambulatory care delivery system. In his role, Todd is helping to establish and strengthen relationships with external medical organizations, to bring new medical groups into the national OptumCare care delivery network, and to develop a research and education capability at OptumCare. Todd worked for more than 30 years in a primary care practice as a general internist, including advising patients who needed to be admitted to the hospital, serving as a nursing home director and as a school physician. He is a founder and former Chairman of ProHealth Physicians, now part of OptumCare.


Beyond the Hospital:  The Role of Retail Clinics, Free Clinics and Urgent Care as Alternative Sites of Care

Friday, April 13, 2018 - 10:30 AM - 11:30 AM

Health care continues to be a complex structure but, despite efforts to improve services, access remains an elusive option for many consumers.  As appointment wait times continue to increase, patient panels fill up, and major medical centers remain inaccessible to undocumented communities the search for medical care that is quick, accessible, and efficient intensifies.  In this panel, we discuss the role that retail clinics, free clinics, and urgent care play in changing the health care landscape.  Are they cost effective?  Do they provide rapid response without sacrificing safety and efficiency? Can they provide positive health outcomes and encourage earlier disease management?

   Will Schpero    Yale Ph.D.  (Moderator)

Amir Mohammad, MBBS, MPH, FACPM

Assistant Clinical Professor of Medicine

Yale School of Medicine

Dr. Amir Mohammad is a board certified Internist and Occupational Medicine Physician. He is a full time VHA based faculty. He attends on inpatient medicine wards and provide medical consultation related to military and post-deployment exposures. Since 2015, he has been co-directing the national VHA Occupational Medicine Tele Consult He is passionate about teaching students, residents, and fellows. In addition, he is a workshop Leader for the Epidemiology, Public Health, & Biostatistics Thread Workshop and Clinical Coach, Yale Inter-professional Longitudinal Clinical Experience (ILCE) at the Yale School of Medicine.

   Emad Rizk    Verscend Technologies

Katharine Miao, MD

Medical Director & Partner

CITYMD

Dr. Katharine Miao is a medical director and partner of CityMD covering the Metro North Region of New York. Prior to joining CityMD in 2013, Dr. Miao served as an Assistant Professor of Emergency Medicine at Albert Einstein College of Medicine as well as a Clinical Instructor of Emergency Medicine at Weill Cornell Medical College. She completed her internship at Lenox Hill Hospital followed by her residency in Emergency Medicine at the Albert Einstein College of Medicine in New York City. A native of Chicago, Dr. Miao received her medical degree from the University of Illinois College of Medicine and her BS in Biology from Yale University. Dr. Miao resides with her husband and two children near New York City, and enjoys theater and travel in her free time.

Robert F. Miller, MD

Professor of Clinical Medicine

Vanderbilt University School of Medicine

Dr. Robert F. Miller is the Patricia and Rodes Hart Professor of Clinical Medicine at Vanderbilt University with board certification in internal medicine, pulmonary medicine and critical care. He practices Pulmonary and Critical Care Medicine at Vanderbilt University Medical Center where he also serves as a medical director and volunteer attending physician for the Shade Tree Clinic. Shade Tree is a free clinic run by Vanderbilt medical students located in one of Nashville’s most underserved communities. Dr. Miller has been a medical director for Shade Tree since the clinic opened in 2005 and is recognized for his interest in patient care and health policy as related to underserved populations.

In 2005, Dr. Miller and colleagues began evaluating a large number of Ft. Campbell soldiers with unexplained exercise limitation following deployment to Southwest Asia. They were the first group to report that their symptoms were due to constrictive bronchiolitis, a condition now linked to deployment in Southwest Asia. Vanderbilt is recognized as a resource for evaluating and treating service members with respiratory disorders associated with deployment He is married to Dr. Bonnie Miller, Senior Associate Dean for Health Sciences Education at Vanderbilt University School of Medicine. They have three children and two grandchildren.

Sharon Vitti, MPA

Senior Vice President & Executive Director

CVS Minute Clinic

Sharon Vitti is Senior Vice President and Executive Director of MinuteClinic. In this role, she leads all aspects of MinuteClinic care delivery, business operations and strategic development. Vitti leads a dynamic team of clinical leaders complimented by health care and retail business leaders, all focused on executing on the MinuteClinic strategies and achieving our mission to help our patients on their path to better health.

Vitti has more than 30 years of experience in health care and has focused on care delivery for the past decade. Prior to joining MinuteClinic in 2014, she held the role of senior vice president of clinical operations at the Brigham and Women’s Hospital in Boston. Vitti was responsible for running a large women’s health hospital, developing a multidisciplinary ambulatory service center, building a successful urgent care practice, and overseeing the successful completion of several multimillion-dollar capital projects. Prior to this, Vitti was a senior manager in national health care consulting practice.

Vitti earned a Bachelor’s Degree from Clark University in Worcester, Massachusetts, and a Master of Public Administration in Hospital and Health Care Facilities Administration/Management from New York University.

Bethany Kieley, MBA

Vice President

Practice Programs & Operations - ProHealth Physicians

Bethany Kieley is Vice President of Practice Programs and Services at ProHealth Physicians, which is part of OptumCare, a leading health care delivery organization that is reinventing health care to keep people healthier and feeling their best. ProHealth is Connecticut’s leading primary care physician organization and an NCQA Level 3-recognized Patient Centered Medical Home. Ms. Kieley has extensive experience in physician practice management, having started her career in health care with The Hitchcock Clinic in Lebanon, NH and later providing management services to physicians in private practice and hospital-owned practices.

Since joining ProHealth Physicians in 2007, Ms. Kieley has served in several operational and leadership roles in the practice operations division. She joined ProHealth in 2007 as a Regional Manager, providing operational oversight for as many as 30 primary care locations. She later became Director of Practice Operations with accountability for integrating new practices, oversight of specialty practices and operations special projects. She subsequently served as Vice President of Practice Operations for 4 years in which she led an operations team that oversaw 80 physicians’ offices with annual revenue of more than $170M. In her current role as Vice President of Practice Programs and Services, Ms. Kieley is charged with expanding access to primary care services and improving the efficiency and effectiveness of ProHealth’s patient care sites. Among the functions she oversees are Marketing and Communications, Process Improvement, Patient Experience and ProHealth’s ten Express Care walk-in centers.

Ms. Kieley earned her Master of Business Administration from Plymouth State University in New Hampshire, and her undergraduate degree in music, with a minor in business, from DePaul University in Chicago.


Aging Populations in Healthcare:  The Impact of Long Term Care and Home Health Access on Health Expenditures and Patient Outcomes

Friday, April 13, 2018 - 2:15 PM - 3:15 PM

Former Vice President Hubert Humphrey once said, “The moral test of government is how that government treats those who are in the dawn of life, the children; those who are in the twilight of life, the elderly; and those who are in the shadows of life, the sick, the needy, and the handicapped."  As healthcare consumes a larger portion of annual GDP and life expectancy increases produce an older population former Vice President Humphrey’s words carry heavier meaning.  In this panel, we discuss the unique potential for long term care and home health access to manage chronic health conditions and the complex health needs of aging populations without exacerbating health expenditures. 

Julia Burgdorf

Julia Burgdorf

Doctoral Student

Johns Hopkins Bloomberg School of Public Health

Julia Burgdorf is a doctoral student in Health Services Research at the Johns Hopkins Bloomberg School of Public Health. Her research focuses on the intersection of family caregiving and formal post-acute and long-term care. She has previously worked as a researcher and consultant for post-acute providers, focusing on home health care. Ms. Burgdorf received her Bachelor’s degree in Policy Analysis and Management with a concentration in Gerontology from Cornell University.

Tracy Wodatch

Tracy Wodatch, RN, BSN, COS-C

Vice President

Clinical & Regulatory Services, Connecticut Association for Healthcare at Home

Tracy is currently the Vice President of Clinical and Regulatory Services at the CT Association for Healthcare at Home in Wallingford, CT. In her role, she serves as the liaison between the home health and hospice provider members and the various state/federal agencies including CMS, DPH, and DSS. She also coordinates legislative advocacy efforts and educational programming, acts as a resource to providers on clinical and regulatory issues, and facilitates multiple association committees.

Tracy also has 35 years nursing experience, both direct care and management, in home health, hospice, long-term and acute care. Tracy is a board member for the CT Partners for Health (an organization to engage consumers to become active, informed partners in managing their health and healthcare); and a member of the CT Medicaid Assistance Provider Oversight Council(MAPOC), Complex Care Committee (subcommittee of MAPOC), Quality of Care Advisory Committee for CT DPH, CT Health Improvement Planning Coalition (DPH), MOLST Steering and Advisory Committees and the newly formed Mobile Integrated Healthcare DPH Working Group.

Tracy received her BSN from the UCONN School of Nursing.

Anne Tumlinson, MS

Chief Executive Officer

Anne Tumlinson Innovations

Anne Tumlinson is the founder of Anne Tumlinson Innovations and Daughterhood. She develops innovative ideas to prepare the country for demographic shifts and to improve how we deliver care to frail older adults. Anne has testified before the U.S. House Energy and Commerce Committee, the U.S. Senate Aging Committee, the Congressional Long-Term Care Commission, and the Bipartisan Policy Center. Her testimony has consistently emphasized the need for care delivery redesign for frail older adults. In support of this work, Anne researches, writes and speaks about innovation in aging services, with blogs in Health Affairs, McKnights, Next Avenue and Maria Shriver. Anne has also created a consumer website, www.daughterhood.org, to create community for families navigating the health and elder care systems on behalf of their loved ones.

Among other affiliations, Anne serves on the board of the directors for the Caregiver Action Network, on the Aetna Medicaid Advisory Panel, and on the conference planning committee for the National Investment Center for Seniors Care.

Andrea Cohen, MSW

Chief Executive Officer

HouseWorks

Andrea Cohen is a social entrepreneur dedicated to transforming the way care is delivered to seniors at home. As HouseWorks co-founder and CEO, her vision crystalized over 20 years ago when she took care of both her parents and made an unwavering commitment to reimagine what it means to age. HouseWorks’ fundamental innovation has been an entrepreneurial approach to service delivery that returns a sense of control to adult children and their parents. In Boston over the last two decades, Andrea and her team built one of the largest single site private home care companies in the country.

A visionary leader, Andrea has leveraged her business accomplishments to create a powerful force for bringing about social change. She served as an adjunct professor at Boston College School of Social Work teaching Innovation and Leadership courses and awarded the Distinguished Alumni Award by Boston College and the Louis Lowy Award by the Massachusetts Gerontology Association. In recognition of her achievements as an entrepreneur, Andrea was named a 2009 Pinnacle Award honoree by the Greater Boston Chamber of Commerce and selected as a finalist for the Ernst & Young Entrepreneur of the Year award. She is a Massachusetts Women Forum appointee and sits on the Board of The Commonwealth Institute, the Caregiver Action Network, the Leadership Council of the Schwartz Center and on the Boston Medical Center Exceptional Care Without Exception Trust. Andrea previously served on the Boards of the Massachusetts Home Care Alliance, the National Private Duty Association, and the Boston College School of Social Work Alumni. She has advised several companies including Care.com, Confidant and Serality—all which provide innovative, online solutions for family caregivers.

A tireless advocate, Andrea was selected as an at-large delegate to the 2005 White House Conference on Aging where she helped influence national policies that impact all seniors and family caregivers and organized the PBS sponsored Boston Family Caregiver Town Hall Meeting. With innovation at the center of all of her accomplishments, Andrea conceptualized Schwartz Center Rounds ® for the home care industry and was a strategic partner to Beacon Hill Village and the StrideRITE corporation’s intergenerational on-site day care center.

Andrea received her MSW from Boston College and completed her BA at Ithaca College in upstate New York.


The Changing Landscape of Venture Capital in Healthcare: Innovating and Financing Next Gen Solutions

Friday, April 13, 2018 - 2:15 PM - 3:15 PM

Over the past decade, healthcare entrepreneurship has boomed with innovators developing solutions that aim to fix the challenges and complexities of the U.S. healthcare system. As the quantity and size of healthcare start-ups on the market continue to rise, investors have financed these solutions through venture capital. This session will explore the growing and changing role of venture capital in healthcare and how investors have helped to bring next generation, high-impact solutions to market. Biotechnology firms have historically commanded the highest VC investments of all healthcare sectors, and investors have played a critical role in expanding and improving access to medications and devices for rare or undertreated conditions accordingly. Population health, digital health and delivery-oriented enterprises have also attracted more funds in recent years. The session will include voices from healthcare investors, entrepreneurs and accelerator leadership.

Dr. Stephen Bloch

Stephen Bloch, MD

General Partner

Canaan Partners

As an early investor and chairman, Steve helped Advanced BioHealing (ABH), a leader in regenerative medicine, grow from a seed stage company to a $750M all-cash acquisition by Shire, generating a 15X return for Canaan. He currently serves on the boards of companies in digital health (Truveris, Ambra Health and Genome Medical); biopharma (Envisia and Liquidia); medical devices (Mitraspan and Onkos); and diagnostics (Sample6).

Before joining Canaan in 2002, Steve founded multiple start-ups, including Radiology Management Sciences (RMS), a pioneer in managing radiology benefits for health plans, where he was CEO for 6 years. Steve obtained his AB from Dartmouth College, received his MA in the history of science and public policy from Harvard, and he earned his medical degree from the University of Rochester. Steve received his medical training at Massachusetts General Hospital/Harvard Medical School (radiology) and Lenox Hill Hospital/Cornell Medical School (internal medicine). It was there that he contracted the entrepreneurial bug - the one thing he admits he can't cure.

Polina Hanin

Polina Hanin

Moonshot Academy Director

StartUp Health

Polina Hanin is the Moonshot Academy Director at StartUp Health, which was founded in 2011 to organize, support, and invest in a global army of Health Transformers to embark on one extraordinary mission: to achieve 10 Health Moonshots, each of which can improve the lives of at least one billion people.

Polina leads the Moonshot Academy, a lifetime program designed to help entrepreneurs succeed at every stage of their business by combining the power of moonshot thinking, a transformer mindset, and collaborative communities. She is the lead relationship manager for the world’s largest portfolio of health innovation companies, now more than 200 companies across 18 countries and six continents.

Prior to joining StartUp Health in 2012, Polina was at Viscogliosi Bros., a merchant bank focused on the orthopedic industry, where she held multiple interim roles within the firm’s portfolio companies. At Centinel Spine, she led M&A deals for the company’s spinal stabilization device portfolio, corporate development and distribution-related operations. She also launched Musculoskeletal Clinical and Regulatory Advisers, a consulting firm for commercializing orthopedic technologies, where she focused on client relations, marketing and corporate finance.

Polina received her B.A. from Wesleyan University and an M.B.A. from the University of Chicago Booth School of Business.

Ethan Rigel, MBA

Founding Partner

Gore Range Capital

Ethan Rigel is the CEO and a Founding Partner of Gore Range Capital. He has more than ten years of investing experience, spending most of his time actively working with small businesses with limited resources. During the course of his career he has invested more than $900M in companies with a combined enterprise value of greater than $2B across dozens of investments. Most of his investments have been very hands-on, with Ethan taking an extensive role in the operations of the business and helping to drive the company’s success.

Vikas Sinha, MBA, CPA

Executive Partner

MPM Capital

Vikas Sinha joined MPM in 2018 as a Managing Director. He brings to this role more than 20 years of experience working in executive finance roles in the life sciences industry and will contribute to the firm’s company-building approach for key portfolio investments. Prior to joining MPM, Vikas served as the CFO of Alexion Pharmaceuticals for 11 years and was responsible for finance, business development, strategy and IT. During his tenure as CFO, Alexion’s market cap grew from $600 million to more than $30 billion and revenue grew from zero to more than $3 billion. He was recognized five times by Institutional Investors with its “Best CFO Award for Biotechnology.”

>

Prior to joining Alexion, Vikas held various positions with Bayer AG in the United States, Japan, Germany and Canada, including Vice President and CFO of Bayer Pharmaceuticals Corporation, USA, Vice President and Chief Financial Officer of Bayer Yakuhin Ltd., in Japan. Vikas received his M.B.A. from the Asian Institute of Management. He is also a qualified Chartered Accountant from the Institute of Chartered Accountants of India and a Certified Public Accountant in the United States. Vikas is currently an independent board member and Audit Committee chair of Verona Pharma Inc.

Ephraim Heller

Ephraim Heller, MBA

CEO & Co-Founder

SynAgile Corporation

Ephraim Heller is the Founding CEO of SynAgile. SynAgile is an eight-person startup developing the OraFuse™ drug delivery system — the first device for continuous oral delivery of drugs. SynAgile’s first product is DopaFuse™, which uses the OraFuse device to continuously deliver levodopa and carbidopa for the treatment of Parkinson’s disease.

Previously, Ephraim was Founding CEO of AngioScore Inc., a balloon angioplasty company acquired by Spectranetics for over $230 million in 2014. Before that, he was Founding CEO and later VP of Marketing and VP of Business Development at TheraSense Inc., a maker of blood glucose monitoring systems for people with diabetes. TheraSense went public in 2001, sales grew to $270 million in 2003, and the company was acquired by Abbott for $1.2 billion in 2004. Ephraimholds over 100 issued US patents. He received a BA in Physics from Harvard and an MBA from Yale. Ephraim lives in Jackson Hole, Wyoming.


Healthcare Policy and the Employee: The Future of Employer-Sponsored Healthcare Coverage

Friday, April 13, 2018 - 2:15 PM - 3:15 PM

Employer-sponsored health insurance has remained an integral component of the U.S. healthcare system for more than fifty years. As political tensions continue over the appropriate means for providing healthcare coverage in the U.S., understanding the unique and important role of employers is critical. This session will focus on employer-sponsored healthcare coverage, discussing its history, recent changes, and necessary policy solutions for the future. It will be relevant for employers, employees, and those innovating coverage outside of employer-sponsored care.

Jacob Wallace

Jacob Wallace, PhD

Assistant Professor of Public Health (Health Policy)

Yale School of Public Health

Jacob Wallace is an Assistant Professor of Public Health (Health Policy) at the Yale School of Public Health. His research is focused on the economics of health insurance markets with particular emphasis on the impact of managed care in public insurance programs. This area of research is growing in importance, as the government is increasingly contracting with managed care plans to deliver benefits in Medicaid and Medicare. Specifically, he conducts work in three areas. The first uses novel administrative claims data and random assignment in Medicaid managed care (MMC) markets to study a variety of questions related to the economics of MMC. Projects include examining how provider networks impact the quality and cost of care recipients receive, measuring how much outcomes vary across (randomly-assigned) managed care plans, and investigating how MMC competition is impacted by the presence of a public option. In other work, he studies how changes in health insurance coverage impact health and financial health. Finally, he is interested in provider performance and efficiency measurement, with a focus on identifying natural experiments that can be leveraged to provide insight into existing approaches to provider measurement and risk adjustment. He received his PhD in Health Policy from Harvard University.

Paul Grady

Paul Grady, MBA

Principal

C.M. Smith Agency, LLC (An Alera Group Company)

Paul Grady is a Principal at the C.M. Smith Agency, LLC. Paul advises employers on human resource issues, with a focus on health and welfare benefit program strategy, including: design, funding, vendor selection, communication and employee engagement. Paul’s clients are typically early adopters of innovative approaches to improving health and health care value. His experience includes start-up and M&A strategy and execution.

In 2010 Paul co-initiated the creation of the Connecticut Business Group on Health, a business group of small and large employers committed to working collaboratively with stakeholders to improve Connecticut health care value. He is currently a board member. In 2013, Paul worked with other stakeholders to form the Connecticut Choosing Wisely Collaborative(CCWC). CCWC is focused on the promotion and adoption of Choosing Wisely principles and practices by key stakeholders in our state. He is currently a board member.

Paul’s past community involvement includes: Sustinet board member, Business Council of Fairfield County Health Care Leadership Council chair, HealthFirst committee member, Connecticut Primary Care Coalition member. He was one of the co-authors of the 2012 Connecticut Health Insurance Exchange Planning Report. Paul holds an undergraduate degree from Villanova University and a MBA from the University of North Carolina at Chapel Hill.

Wendy Sherry

President

Cigna Connecticut and Payer Solutions

Wendy Sherry is the President of Cigna Connecticut and Payer Solutions (TPA business) where she has overall responsibility for distribution, network, strategy development, operations and financial results for these business segments. Sherry is focused on growing market share through delivering superior value and a differentiated experience to those we serve.

Prior to assuming the President role, Sherry was the Chief Operating Officer for New England providing the leadership, management and vision necessary to develop and execute against the local market strategy. In this capacity she was responsible for the collaboration and integration of functional support areas aligned to the market, overseeing the local market management process and ensuring talent was in place to effectively grow the market.

Formerly, Sherry was Vice President of Product Development responsible for products and business initiatives focused on improving quality and affordability for Cigna's clients and customers. Sherry joined Cigna in 1995 and has held numerous positions at Cigna, including roles in product, financial analysis and planning, reporting, and medical management. She is a graduate of Cigna's Financial Development Program.

Before joining Cigna, Sherry was a manager with Ernst & Young. Sherry serves on the board of the Governor’s Prevention Partnership, which helps organizations, communities and families prevent substance abuse, underage drinking and violence among Connecticut youth.

Sherry is a summa cum laude graduate of Emory University (BBA, 1990) and a former Certified Public Accountant.

Mary Bradley

Director of Health Care Planning

Pitney Bowes

Mary Bradley is the Director of Health Care Planning for Pitney Bowes, a $3.9 billion global technology company blending physical and digital transactions to enable advanced commerce for clients. Mary is responsible for the development of the U.S. Health Care strategy including quality assessment of health care programs, management of health care suppliers, development and management of the health care budget for Pitney Bowes’ U.S. 12,000 active and retired employees and their dependents.

Mary serves on advisory boards for Cigna, NCQA and Beacon Health Options and co-chairs the Health Transformation Alliance Medical Services workgroup. Mary also serves on the State of CT Healthcare Innovation steering committee. She is the past Chair of the Corporate Board for the International Foundation of Employee Benefit Plans and the Northeast Business Group on Health.

Mary received the 2008 Employer Award for Value Based Purchasing from the National Business Coalition on Health, and a Solutions Superstar award in 2009 and 2010. On behalf of Pitney Bowes, she has accepted: the Truven 2012 Healthcare Advantage Award for performance efficiency as well as the overall performance award; the 2013 Healthcare Advantage Award for performance efficiency; the 2012 National Business Group on Health award for Innovation in Reducing Health Care Disparities (along with UnitedHealthcare) and a certificate of appreciation from HHS; the American Well’s 2016 Client Achievement Award for Telehealth Leadership.

Gary Loveman, PhD

Former President of Consumer Health and Services, Aetna, and Former Chairman and CEO, CAESARS Entertainment Inc.

Gary Loveman, Ph.D., joined Aetna in October 2015 serving as President of Consumer Health and Service, Aetna’s health services business through January 2018. The Consumer Health and Services organization is responsible for helping Aetna members achieve their best health and for fostering innovative collaborations with health care providers to improve the overall quality, cost and experience for Aetna members. Dr. Loveman led the company’s population health management and consumer engagement strategies, health and clinical services, care management, digital consumer health products, analytics and data science, pharmacy and marketing areas.

Prior to joining Aetna, Dr. Loveman served as Chairman, CEO and President of Caesars Entertainment Corporation. During his seventeen year tenure, Dr. Loveman oversaw a period of growth that included several major acquisitions making Caesars the largest and most diversified company in the gaming industry. In 2008, Caesars went private in a $30.7B transaction led by Apollo and TPG. He pioneered the use of cutting-edge technology and data analytics to deliver unsurpassed customer service and consumer experiences. Dr. Loveman also led the development of Wellness Rewards, Caesars’ widely recognized, incentive-based health and wellness program for the company’s 70,000 employees and their families. He was voted “Best CEO in the Hospitality Industry” for four consecutive years by the Institutional Investor magazine and was inducted into both the Hospitality and Gaming Halls of Fame.

From 2012-2015, Dr. Loveman chaired the Business Roundtable’s Health & Retirement Committee, which focuses on improving the quality and affordability of the nation’s health and retirement systems. Earlier in his career, Dr. Loveman was an associate professor at Harvard Business School, where he taught service management. He holds a Ph.D. in economics from M.I.T., where he was an Alfred Sloan Doctoral Dissertation Fellow, and a bachelor’s degree in economics from Wesleyan University. He serves on the Board of Trustees at Boston Children’s Hospital and served previously on the Visiting Committee of the M.I.T Department of Economics and the boards of FedEx, Coach and Ventas, Inc.


The Role of Partnerships in Improving Population Health: Who Should Partner, for What and How? 

Friday, April 13, 2018 - 2:15 PM - 3:15 PM

With the shift towards population health well underway, there is increasing focus on integrating services beyond the four walls of the hospital to improve the health of communities overall. This movement has not only included new roles for non-profit organizations (e.g., legal aid), but also for a wide range of private partners. This session will explore a range of innovative partnerships aimed at achieving the Triple Aim. How are these partnerships structured and financed? What leads to their success; and, equally important, what hinders them?

Lauren Taylor

Lauren A Taylor, MDiv, MPH

PhD Candidate

Harvard Business School

Lauren A Taylor is a health services researcher based at Harvard Business School, where is she is earning her doctorate in health policy and management. Prior to joining HBS, Lauren co-authored a book titled The American Health Care Paradox, which has become required reading at a variety of medical and public health schools across the country. Lauren's work focuses on organizational theory and strategy in health care, with a particular emphasis on the integration of health and social services. She holds a BA in the History of Medicine and a Master in Public Health from Yale University. She has also worked as a health care chaplain and studied ethics as a Presidential Scholar at Harvard's Divinity School.

Megan Mariotti

Megan Mariotti, NP, MPH

Assistant Director of Operations

Acceleration Lab at the Penn Medicine Center for Health Care Innovation

Megan Mariotti is the assistant director of operations for the Acceleration Lab at the Penn Medicine Center for Health Care Innovation. In this role, Megan designs and executes projects and provides oversight of Center operations, including staffing allocation and business plan development.

Prior to joining the team, Megan worked as a senior clinical project manager in the Department of Quality & Safety at Atrius Health in Boston, where she led Accountable Care Organization (ACO) quality reporting and chronic disease management efforts. At Geisinger Health System, Megan was a quality improvement specialist and nurse practitioner in a pediatric weight management program. She also completed an administrative fellowship at Harvard University Health Services and worked as a staff nurse on the general pediatric floor at New York Presbyterian Weill-Cornell Medical Center. She is a member of the board of directors at the HSC Foundation in Washington, DC.

Megan completed a bachelor’s degree in nursing at the University of Pennsylvania, a master’s degree in nursing as a pediatric nurse practitioner at the University of Pennsylvania, and a master of public health with a focus on health policy and management at the Harvard School of Public Health.

Katherine Kraschel, JD

Visiting Clinical Lecturer in Law, Research Scholar, and Executive Director of the Solomon Center

Yale Law School

Katherine L. Kraschel is the Executive Director of the Solomon Center for Health Law and Policy as well as a Visiting Clinical Lecturer in Law at Yale Law School. She co-teaches the Reproductive Justice Clinic and the Medical-Legal Partnership Seminar. Previously, Kraschel was Associate Counsel at Yale New Haven Health System, focusing on corporate regulatory work including affiliations, clinical research, and Stark and Anti-kickback compliance. Prior to that, Kraschel was an associate at Foley & Lardner’s Boston office and worked in their health care practice group. She also completed Harvard Medical School’s Fellowship in Bioethics and serves on Yale New Haven Hospital’s Ethics Committee. Prior to pursuing a career in law, Kraschel worked as a scientist at Pfizer. She holds a bachelor’s degree in biochemistry from Mount Holyoke College and a law degree from Harvard Law School, where she was a student fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics as well as Submissions Editor of the Harvard Journal of Law & Gender. She also served on the Mount Holyoke College Board of Trustees.

Kraschel has lectured on and published in the health law and bioethics space, and is particularly interested in assisted reproductive technologies, health policy & gender, reproductive rights, and clinical research ethics. Most recently, she co-authored a chapter in The Handbook of Gestational Surrogacy – International Clinical Practice and Policy Issues. She is also interested in non-profit law, higher education, and governance. In 2016, the National LGBT Bar Association named Katie one of the Best LGBT Lawyers Under 40.

Alejandro Reti, MD, MBA

Chief Medical Officer

Optum Analytics

With responsibility for the office of the CMO, Alejandro is accountable for the clinical integrity and relevance of Optum Analytics' provider and payer solutions and contributes to thought leadership and clinical product innovation for the organization. Alejandro came to Optum from Premier, where he served as Vice President, Population Health Products with general management responsibility for Premier's organically developed population health suite. Prior to Premier, Alejandro served as Senior Vice President, Clinical Informatics at Verisk Health, where he led development of a provider analtics solution that achieved top 4 in market share nationally.

Previously, Alejandro held positions of increasing responsibility at Avalere Health and The Advisory Board Company. Alejandro received a bachelor's degree in Psychology from Amherst College, magna cum laude and his MD and MBA degrees from Yale University.

Douglas Olson, MD, FACP

Vice President of Clinical Affairs

Fair Haven Community Health Care

As the Vice President of Clinical Affairs, Dr. Douglas Olson is responsible for clinical integration among medical, behavioral health, addiction medicine and dental programs at Fair Haven Community Health Care. A native of Boston, MA, Dr. Olson graduated from George Washington University School of Medicine in Washington, DC. He completed residency and chief residency in internal medicine/primary care at Yale. He is board certified in both internal medicine and addiction medicine.

Since being an intern for Senator Edward Kennedy as a college student, Dr. Olson has had a firm commitment to health equity and eliminating health disparities. He is passionate about creating and improving clinical-community partnerships that positively impact all patients and staff. He is active in health reform and advocacy, serving on the State of CT Practice Transformation Task Force and also on the State of CT Medical Examining Board. Dr. Olson lives in Cheshire, CT with his husband, Justin and their two dogs, Roxy and Kane.


Battling Inequity:  The Role of Community Stakeholders in Addressing Social Determinants of Health Across the Care Continuum

Friday, April 13, 2018 - 2:15 PM - 3:15 PM

Despite continuous breakthroughs in medical research and advances in developing novel pharmaceutical agents, there continues to be rampant health inequity.  Chronic and acute conditions alike continuously plague communities along socio-demographic axes including race, gender, and socioeconomic status.   As health care shifts toward a preventative care lens the question on everyone’s minds remains – how do we stop health inequity and who can play a role?  In this panel, we discuss the role of local community members (i.e. stakeholders) in ameliorating health inequity before, during, and after acute medical care.  We will explore not just the potential for local mobilization but how to maintain and enhance these movements. 

Darin Latimore

Darin Latimore, MD

Deputy Dean for Diversity & Inclusion

Yale School of Medicine

Darin A. Latimore, MD, has been Deputy Dean for Diversity and Inclusion since January 2017, and is the School of Medicine’s inaugural Chief Diversity Officer. Alongside YSM senior leadership, Dr. Latimore is responsible for developing a comprehensive plan for furthering diversity, equity, and inclusion at the school, including a robust recruitment and retention program for faculty, and students from historically underrepresented in medical communities. He coordinates with such groups as the Inclusion, Community, Engagement & Equity (DICE), the Minority Organization for Retention and Expansion (MORE), the Committee on the Status of Women in Medicine (SWIM), the Committee on Diversity, Inclusion, and Social Justice, and the Dean’s Advisory Council on LGBTQ Affairs.

Dr. Latimore’s passion for promoting diversity and inclusion stems from his own background. As an undergraduate at University of California, Berkeley, he felt isolated on a campus where there were few African-Americans and even fewer students from his socioeconomic background. After obtaining his medical degree at University of California, Davis School of Medicine and completing his residency in internal medicine at University of California, Davis Medical Center, he worked as a physician specializing in HIV care with The Permanente Medical Group in South Sacramento, CA where he also trained medical students and residents.

His transition to academic medicine began with his appointment as Associate Program Director for the UC Davis internal medicine residency program. Many of the students and residents with whom he worked shared his experiences of isolation and discrimination, prompting him to write a job description that led to his inaugural position as Director of Medical Student Diversity at UC Davis in 2008, a position he held until joining Yale in 2017. Since August, as a part of his current strategy to improve the cultural climate for all of YSM, Dr. Latimore has given over 26 focused talks on the topic of unconscious bias.

Carl Sciortino

Carl Sciortino, MPA

Executive Director

AIDS Action Committee

Carl Sciortino is the Executive Director of AIDS Action Committee, and has served in this capacity since 2014. AIDS Action Committee is New England’s oldest and largest AIDS service organization, providing services for people living with and at risk of getting HIV, and is the state’s leading advocate for public policy reflective of the needs of these communities. Prior to being Executive Director, Carl was a State Representative in the Massachusetts Legislature. There, he was the leading legislative advocate on HIV-related legislation. These include measures to increase funding for HIV-related services; a bill that would require health insurers to cover the costs of treatment of lipodistrophy; and a law that expands HIV testing in Massachusetts. Sciortino, who is living with HIV, has championed social justice issues throughout his career, including the right of same-sex couples to marry; banning discrimination against transgender people; expanding access to health care; and increasing resources for anti-poverty programs. He received his Bachelor of Science from Tufts University and earned his Masters in Public Administration at the Kennedy School of Government at Harvard University.

Byron Kennedy, MD, PhD, MPH

Director of Health

New Haven Health Department

Dr. Byron Kennedy is the Director of Health for the City of New Haven. In this leadership role, he directs the City’s community health initiatives through programmatic and collaborative efforts across multiple areas (e.g., communicable disease, maternal child health, environmental health, and chronic disease). Previously, Dr. Kennedy served as the Commissioner of Public Health for Monroe County in Rochester N.Y. Prior to this assignment, Dr. Kennedy provided health policy expertise to The California State Legislature, where he also served as the lead staffer for a statewide Healthy Communities Initiative focused on improving the health status of medically underserved populations by developing prevention strategies with limited resources.

Dr. Kennedy is Board Certified in Preventive Medicine and is experienced in occupational medicine, urgent care, and general practice clinics. He is a graduate of Yale University (MD, PhD, and MPH degrees). He has published papers in the areas of communicable disease outbreaks, chronic disease treatment, tobacco control, repetitive use-injury, and health disparities.

Darcey Cobbs-Lomax, MBA, MPH

Executive Director

Project Access - New Haven

Darcey Lynn Cobbs-Lomax is the Executive Director of Project Access of New Haven (PANH). She received her Bachelor’s Degree from Florida State University in French with a concentration in finance, her Masters of Business Administration Degree from Georgia State University with a concentration in personnel and employment relations and her Masters of Public Health Degree from Walden University with a concentration in community health.

Darcey’s public health career began in 2002 while working for the New York City Health and Hospitals Corporation with a Women, Infants and Children program. It was while working in a small clinic in the South Bronx that Darcey realized her calling was to work with the underserved in her community. Over the next ten years Darcey’s work brought her to Harlem Hospital Center where she served as an Administrator in their Infectious Disease Clinic and then to New Haven Connecticut where she worked with the City of New Haven Health Department and their Asthma initiative. In this role Darcey lead an asthma management collaborative with representatives from neighboring towns actively looking for solutions to the increasing rates of Emergency Room visits for asthmatic children. Darcey honed her human service skills as the Director of Elderly Services for the City of New Haven, and then traveled to the position of Manager, Business Operations at the Yale- YNHH Center for Outcomes Research and Evaluation before coming to PANH

Darcey is committed to improving community health and dedicated to working with the underserved. She is a graduate of the Connecticut Health Foundation 2014 Leadership Fellows Class and served as a Senior Fellow during the 2014-2015 program year. She is currently enrolled in the CT Health Foundation Academy for Health Equity Leadership where she is working on a health equity legislative project supporting reimbursement for patient navigation. She has a commitment to her community and making an impact and is a past Board member of the Fair Haven Community Health Center and the Southern Regional Sickle Cell Association. She is currently a member of the Partnership for a Healthier Greater New Haven and serves as the co-chair of the access to care subcommittee.

Darcey’s collaborative work in healthcare access and health equity has been published in peer reviewed journals including the Academy of Emergency Medicine and she frequently presents at national conferences. Most recently Darcey gave the key note address at the American Academy on Communication in Healthcare conference with her talk entitled“Lost in translation. Can you hear me now? The voice of the patient in the healthcare setting.” Also notably she recently presented collaboratively at the Society For General Internal Medicine conference on the role and benefit of Patient Navigators and Community health workers.

Darcey is married and a mother of 4 children. In addition to her work in heath equity Darcey volunteers as a Girl Scout Troop Leader with the Girl Scouts of Connecticut and as a Merit Badge counselor with the Boy Scouts of America. She is a member of Jack and Jill of America, and Alpha Kappa, Alpha Sorority. In her free time she enjoys sewing and gardening.

Gina Federico

Director

North Hartford Partnership for Community Solutions, Inc.

Gina directs the the North Hartford Triple Aim Collaborative (NHTAC), launched in 2017 by Community Solutions in partnership with the City of Hartford, multiple organizations, and residents to improve the "triple aim" of health, well being and investability of the city’s North End.

Gina previously led Community Solutions’ Hartford neighborhood initiative and strategic partnerships. She has more than 20 years experience in non-profit leadership, with almost 10 years in hospital systems including UCONN’s John Dempsey Hospital and Boston Children’s Hospital. She is a Connecticut Health Foundation Academy for Health Equity and Advocacy and Leadership Fellow, a Corporator for the Hartford Public Library and a Corporator for Connecticut Community Care, Inc and a Board Member for the Connecticut Legal and Education Fund.